Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.51 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.44 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.44 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811121 | 0.98 | CYP11B1 (0.50) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL13074509 | 0.85 | CYP2A6 (0.50) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL29489119 | 0.85 | CYP2A6 (0.54) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL1344485 | 0.85 | CYP2A6 (0.54) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL1341822 | 0.83 | CYP2A6 (0.52) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL29489123 | 0.83 | CYP2A6 (0.52) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL1104942 | 0.83 | CYP2A6 (0.54) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL806471 | 0.82 | CYP2A6 (0.59) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL6924028 | 0.80 | CYP2A6 (0.61) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 | |
| SCHEMBL2761110 | 0.79 | CA1 (0.57) | CYP11B1CYP11B2CYP2A6ALDH1A1IMPDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | C9, C5, RNF168 | CYP11B1 465/4885CYP11B2 602/4885CYP2A6 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.